Drawing for Serial No. 76212606

USPTO serial 76212606

Serial No. 76212606

Reviewed by CopyMark Law Group

Reg. 2706100Status 710
Filing date
Status date
Registration date
Apr 15, 2003
Examiner
CHARLON, BARNEY
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 76212606?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Blood products, namely, plasma volume expanders, blood plasma, human albumin, blood clotting factors and immunoglobulins for medical and clinical use; pharmaceutical preparations derived from plasma and recombinant DNA technology for the prevention and/or treatment of blood disorders; products derived from recombinant DNA technology, namely, plasma volume expanders; human albumin, blood clotting factors and immunoglobulins for medical or clinical useSECTION 8 - CANCELLED
016Printed matter and publications, namely, books, magazines, newsletters, brochures, leaflets and periodicals all featuring material in relation to pharmaceutical products, blood, blood products, bleeding disorders and blood fractionation; printed educational and teaching material in the field of pharmaceutical products, blood, blood products, bleeding disorders and blood fractionation; stationery; calendars and postersSECTION 8 - CANCELLED
040Treatment of human biological products, namely, custom manufacturing and fractionation of blood, and transformation of blood products and products derived from blood and/or recombinant DNA technologySECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2009C8..CANCELLED SEC. 8 (6-YR)
Mar 17, 2008CFITCASE FILE IN TICRS
Apr 15, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 21, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 1, 2003NPUBNOTICE OF PUBLICATION
Nov 22, 20021.BDSec. 1(B) CLAIM DELETED
May 13, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2002CNEAEXAMINERS AMENDMENT MAILED
Feb 11, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 15, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance